Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Short-term esomeprazole treatment resolves reflux symptoms in patients with nonerosive symptomatic gastro-oesophageal reflux disease (gord) and frequent heartburn

  • In: Posters: Community Pharmacy: Better outcomes for tomorrow
  • At: Bangkok (Thailand) (2014)
  • Type: Poster
  • Poster code: POS-CPS141
  • By: KATZ, Philip (Einstein Medical Center, Division of Gastroenterology, Philadelphia, United States of America)
  • Co-author(s): Le Moigne, Anne (Pfizer Consumer Healthcare, Madison, United States of America)
    Park, Kelly (Pfizer Consumer Healthcare, Madison, United States of America)
    Pollack, Charles (Pfizer Consumer Healthcare, Madison, United States of America)
  • Abstract:

    Background: Pharmacists are often asked about short-term treatments of reflux symptoms such as heartburn (HB) and acid regurgitation. We evaluated 14-day efficacy from 2 similarly designed randomized controlled studies of esomeprazole (ESO) 20 mg and 40 mg in patients likely to seek self-treatment in a pharmacy setting.
    Setting: Study 1 (N=368)..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses